Anne has 20-year experience in Market Access and Health Economics in the pharmaceutical industry, where she leads International health economics and market access functions, including at Pfizer, Amgen, Daiichi-Sankyo and Allergan. With her teams she developed the strategy of multiple compounds in the European environment focussing on meeting the needs of payers at national, regional and local levels. She has hands-on experience in establishing strategies and leading their cross-functional execution, integrating all elements of product value in particular clinical and safety profile, health economics and price. She believe that through engagement of all partners involved in the delivery of health care including payers the best value will be achieved for patients and citizens ultimately financing care. She is a physician by training with qualification in Health Economics and Epidemiology. She is currently at Brunel University. Her research uses pain as a model to develop patient centricity and its inclusion in decision making.